Scott Stromatt is EVP & Clinical Dev & Reg Affair at CELL THERAPEUTICS INC (CTIC). They have made 1 open-market trade across 1 company since 2006, most recently 2008-04-04.
CIK 0001187053
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTIC | 65,786 | $598K |
Shares reported on the most recent Form 4, priced at the 2008-04-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTIC | SELL · 10b5-1 | 2007-08-31 | 2007-09-04 | $3.87 | $2K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2006-12-22 | 2006-12-22 | $1.81 | $36K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2006-12-13 | 2006-12-15 | $1.89 | $14K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2006-08-30 | 2006-09-01 | $1.54 | $4K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2006-06-20 | 2006-06-22 | $1.40 | $28K | -2.5% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.